Literature DB >> 16039500

Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage: experimental model.

José I Belda1, Alberto Artola, María D García-Manzanares, Consuelo Ferrer, Hazem E Haroun, Ahmed Hassanein, Vincent Baeyens, Gonzalo Munoz, Jorge L Alió.   

Abstract

PURPOSE: To evaluate the protective properties of combined sodium hyaluronate 2% and mannitol 0.5% (Visiol) on the corneal endothelium in the presence of oxidative stress induced by hydrogen peroxide (H(2)O(2)).
SETTING: Instituto Oftalmológico de Alicante, Universidad Miguel Hernández, Alicante, Spain.
METHODS: This was an exploratory randomized controlled parallel-group, masked-assessor study of 3 sodium hyaluronate-based ophthalmic viscosurgical devices (OVDs): Visiol, Healon (sodium hyaluronate 1%), and Viscoat (sodium hyaluronate 3%-chondroitin sodium 4%). The OVDs were tested for protective effects on the endothelium following oxidative stress induced by H(2)O(2) at increased concentrations: control (lactated Ringer's solution), 1 mM, 10 mM, and 100 mM. Groups without OVD were used as controls at the same concentrations of peroxide. Each animal received the same treatment in both eyes (10 eyes per group). Endothelial cell lesion was assessed using the Janus green photometry absorbance technique.
RESULTS: At 10 mM peroxide concentration, the value of endothelial cell lesion was significantly lower in the Visiol (16.8%, P=.0056), Healon (22.2%, P=.0302), and Viscoat (21.6%, P=.0336) groups than in the control group (29.4%, no OVD). There was a trend in favor of Visiol to more efficiently reduce cell lesions of the endothelium, than Healon (P=.055) and Viscoat (P=.1013). Values of endothelial cell lesion at peroxide concentrations of 1 mM and 100 mM showed the same trends than those observed at 10 mM.
CONCLUSIONS: All of the OVDs tested efficiently reduced endothelial lesions against free radicals compared with the control group in which no OVD was used. The following sequence for the efficacy of endothelial cell protection was established: Visiol>Viscoat>Healon>no OVD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039500     DOI: 10.1016/j.jcrs.2004.11.055

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  10 in total

1.  The injection of DisCoVisc into the anterior chamber improved corneal preservation and transplantation for cornea blind patients.

Authors:  Bing Li; Li Chen; Yihui Chen; Jiajun Lu; Hao Liu; Yu Liu; Panpan Yao; Rui Liu; Minjie Sheng
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

2.  The efficacy, longevity, and safety of combined radiofrequency treatment and hyaluronic Acid filler for skin rejuvenation.

Authors:  Hyuk Kim; Kui Young Park; Sun Young Choi; Hyun-Ju Koh; Sun-Young Park; Won-Seok Park; Il-Hong Bae; Beom Joon Kim
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

3.  A Randomized, Evaluator-Blinded, Split-Face Comparison Study of the Efficacy and Safety of a Novel Mannitol Containing Monophasic Hyaluronic Acid Dermal Filler for the Treatment of Moderate to Severe Nasolabial Folds.

Authors:  Byung Wook Kim; Ik Jun Moon; Woo Jin Yun; Bo Young Chung; Sang Duck Kim; Ga-Young Lee; Sung Eun Chang
Journal:  Ann Dermatol       Date:  2016-05-25       Impact factor: 1.444

4.  Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress.

Authors:  Thierry Conrozier; Pierre Mathieu; Marguerite Rinaudo
Journal:  Rheumatol Ther       Date:  2014-07-25

5.  Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial.

Authors:  Yves Henrotin; Francis Berenbaum; Xavier Chevalier; Marc Marty; Pascal Richette; François Rannou
Journal:  BMC Musculoskelet Disord       Date:  2017-05-26       Impact factor: 2.362

6.  Gait analysis following single-shot hyaluronic acid supplementation: a pilot randomized double-blinded controlled trial.

Authors:  Luis Carlos Pereira; Claude Schweizer; Sara Moufarrij; Swenn M Krähenbühl; Julien Favre; Gerald Gremion; Lee Ann Applegate; Brigitte M Jolles
Journal:  Pilot Feasibility Stud       Date:  2019-04-22

7.  D-sorbitol can keep the viscosity of dispersive ophthalmic viscosurgical device at room temperature for long term.

Authors:  Eiji Nogami; Ippei Watanabe; Hirotaka Hoshi; Masakazu Kasahara; Naoto Honda; Miwako Sato; Kiyoshi Suzuki
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

8.  Thickness of the Protective Layers of Different Ophthalmic Viscosurgical Devices During Lens Surgery in a Porcine Model.

Authors:  Melanie Wüst; Philipp Matten; Magdalena Nenning; Oliver Findl
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

9.  EFFECT OF LUBRICANTS ON CORNEAL THICKNESS AFTER VITRECTOMY.

Authors:  Diane T Siegel; G Baker Hubbard; Jiong Yan; Blaine Cribbs; Nieraj Jain; Steve Yeh; Diem Bui; Jesse Smith; Scott Barb; William Pearce; Laura Ward; Andrew M Hendrick
Journal:  Retina       Date:  2020-08       Impact factor: 3.975

Review 10.  STYLAGE®: a range of hyaluronic acid dermal fillers containing mannitol. Physical properties and review of the literature.

Authors:  Marcia Ramos-E-Silva; Lívia Arcanjo Fonteles; Cecília Schubert Xavier Lagalhard; Ana Paula Cercal Fucci-da-Costa
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.